Cardiac rehabilitation and risk reduction: time to "rebrand and reinvigorate"

Pratik B Sandesara; Cameron T Lambert; Neil F Gordon; Gerald F Fletcher; Barry A Franklin; Nanette K Wenger; Laurence Sperling

doi:10.1016/j.jacc.2014.10.059

Cardiac rehabilitation and risk reduction: time to "rebrand and reinvigorate"

J Am Coll Cardiol. 2015 Feb 3;65(4):389-395. doi: 10.1016/j.jacc.2014.10.059.

Authors

Pratik B Sandesara¹, Cameron T Lambert¹, Neil F Gordon², Gerald F Fletcher³, Barry A Franklin⁴, Nanette K Wenger¹, Laurence Sperling⁵

Affiliations

¹ Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
² Intervent International, Savannah, Georgia.
³ Mayo Clinic, Rochester, Minnesota.
⁴ Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, Michigan.
⁵ Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia. Electronic address: lsperli@emory.edu.

PMID: 25634839
DOI: 10.1016/j.jacc.2014.10.059

Abstract

Atherosclerotic cardiovascular disease (ASCVD) continues to increase annually in the United States along with its associated enormous costs. A multidisciplinary cardiac rehabilitation (CR) and risk reduction program is an essential component of ASCVD prevention and management. Despite the strong evidence for CR in the secondary prevention of ASCVD, it remains vastly underutilized due to significant barriers. The current model of CR delivery is unsustainable and needs significant improvement to provide cost-effective, patient-centered, comprehensive secondary ASCVD prevention.

Keywords: exercise; heart disease; secondary prevention.

Publication types

Review

MeSH terms

Atherosclerosis / prevention & control
Atherosclerosis / rehabilitation*
Coronary Artery Disease / prevention & control
Coronary Artery Disease / rehabilitation*
Exercise
Humans
Rehabilitation / trends
Risk Reduction Behavior
Secondary Prevention
United States